MedTrace Logo

HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence

NCT01369056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-05-26

No results posted yet for this study

Summary

The general objective of this study is to evaluate HAART adherence in Estonia and the factors affecting adherence; and the impact of an individual adherence enhancement counselling and treatment monitoring model (Advanced Adherence, AdvAdh), compared to the regular counselling received by HAART patients.

Conditions

  • Acute HIV Infection
  • Acquired Immunodeficiency Syndrome
  • Medication Adherence

Interventions

BEHAVIORAL

Advanced Adherence Counseling (AdvAdh)

AdvAdh consists of 3 individual sessions (study months 0, 3, 6) -- patient-centered, non-judgmental, Motivational Interviewing- and theory-based, semi-structured, brief, candid conversations with a trained clinical care nurse using Next Step Counseling (NSC) approach. The intervention targets: 1) accurate information about antiretroviral treatment (ART) (mechanisms of HIV and antiretrovirals) and the development of mental imagery around it; 2) promotion of perceived sense of ease and efficacy in working ART regimen into the context of one's daily life and present life circumstances that may challenge drug use persistence; 3) identification, refinement of skills promoting ease of adhering to one's ART regimen across the diverse and challenges contexts.

Sponsors & Collaborators

  • State University of New York - Downstate Medical Center

    collaborator OTHER

  • Tibotec Pharmaceutical Limited

    collaborator INDUSTRY

  • University of Tartu

    lead OTHER

Principal Investigators

  • Anjali Sharma, MD, MSc · State University of of New York Downstate Medical Center

  • Anneli Uusküla, MD, MSc, PhD · University of Tartu Department of Public Health

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Estonia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01369056 on ClinicalTrials.gov